Cargando…

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways

Detalles Bibliográficos
Autores principales:	Mountzios, Giannis, Banna, Giuseppe Luigi, Rolfo, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523870/ https://www.ncbi.nlm.nih.gov/pubmed/36185302 http://dx.doi.org/10.3389/fonc.2022.997404

Ejemplares similares

Editorial: New strategies to tackle chemoresistance in cancer
por: De Marco, Carmela, et al.
Publicado: (2022)

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies
por: Jin, Shenhe, et al.
Publicado: (2022)

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells
por: Saida, Yu, et al.
Publicado: (2023)

Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets
por: Cavallari, Ilaria, et al.
Publicado: (2023)

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies
por: Pasello, Giulia, et al.
Publicado: (2022)

Editorial: Methods in thoracic oncology
por: Stojšić, Jelena, et al.
Publicado: (2023)

Editorial: Reviews in thoracic oncology
por: Kanellakis, Nikolaos I.
Publicado: (2023)

Editorial: Molecular predictive pathology in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2023)

A new approach to overcoming resistance to immunotherapy: nanotechnology
por: Shao, Jiangbo, et al.
Publicado: (2023)

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis
por: Addeo, Alfredo, et al.
Publicado: (2019)

Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis
por: Tabana, Yasser, et al.
Publicado: (2021)

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
por: Mountzios, Giannis, et al.
Publicado: (2008)

Editorial: Overcoming drug relapse and therapy resistance in NSCLC
por: Parakh, Sagun, et al.
Publicado: (2023)

Editorial: Overcoming the cell membrane to target intracellular oncoproteins
por: Brown, Christopher J., et al.
Publicado: (2023)

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy
por: Seiffert, Martina, et al.
Publicado: (2022)

Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies?
por: Mutti, Luciano, et al.
Publicado: (2023)

Editorial: Molecular pathology and computational image analyses in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2022)

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
por: Nayyar, Gaurav, et al.
Publicado: (2019)

The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer
por: Pharaon, Rebecca R., et al.
Publicado: (2021)

Can Natural Products be Used to Overcome the Limitations of Colorectal Cancer Immunotherapy?
por: Dong, Jiahuan, et al.
Publicado: (2022)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

Editorial: Personalized immunotherapy for cancer
por: Pasetto, Anna, et al.
Publicado: (2023)

Editorial: The role of immunotherapy in melanomas
por: Fateeva, Anna, et al.
Publicado: (2023)

Editorial: Insights in thoracic oncology: 2021/2022
por: Parikh, Kaushal, et al.
Publicado: (2022)

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
por: Godwin, P., et al.
Publicado: (2013)

Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer
por: Giunta, Emilio Francesco, et al.
Publicado: (2022)

Overcoming the barriers to tackling childhood obesity
por: The Lancet Regional Health – Western Pacific
Publicado: (2023)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model
por: Jallad, Mary-Ann N., et al.
Publicado: (2020)

Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review
por: Hui, Caressa, et al.
Publicado: (2021)

Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2023)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Editorial: The Biological Landscape of Immunotherapy in AML
por: Isidori, Alessandro, et al.
Publicado: (2021)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Editorial: Engineered Targeted Cancer Immunotherapies
por: Fantini, Massimo, et al.
Publicado: (2022)

Editorial: Impact of immunotherapy in lung cancer
por: Ferreira, Marion, et al.
Publicado: (2022)

Editorial: Microbiota and metabolites in cancer immunotherapy
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Editorial: Imaging assessment of response to immunotherapy
por: Occhipinti, Mariaelena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7q5ttvvf7pleid0nupth53dpft